Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

A woman developed male characteristics after using unregulated hormone therapy.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

Zinc levels are not significantly linked to the presence or severity of alopecia areata.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Ayurvedic treatment improved symptoms and reduced TSH levels in a hypothyroidism patient.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

PCOS phenotypes A and B are more common and linked to higher health risks in women from the Ecuadorian Andes.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

The desmopressin stimulation test helped identify an adrenal cause for a patient's Cushing's syndrome.

Women with Polycystic Ovary Syndrome have higher levels of the hormone ghrelin, which may be linked to the cause of the condition.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.